Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
In the Phase 2 obesity trial published in NEJM in 2023, retatrutide at the 12 mg weekly dose produced a mean placebo-adjusted body weight reduction of 22.1 percentage points (22.1% (24.2% arm) mean absolute reduction on the retatrutide arm) at 48 weeks (Jastreboff et al., NEJM, 2023)
De este modo, si eres deportista, sera una magnfica opcin consumirlo
Presented for research literature review only Holmes HC et al
Clinical weight loss is driven by the active ingredient, semaglutide
US$ 27.73
US$ 27.61
US$ 24.37
US$ 24.23
US$ 25.88
US$ 26.97
US$ 22.47
US$ 23.33
US$ 20.83
US$ 26.80
US$ 25.33
US$ 26.95
US$ 26.30
